Long-term Follow up of the Stability 1 Trial
STABILITY LTF
1 other identifier
interventional
510
2 countries
8
Brief Summary
From 2014-2017, across 7 Canadian and 2 European sites, we randomized 618 patients at high-risk of re-injury, to anterior cruciate ligament reconstruction (ACLR) with or without a lateral extraarticular tenodesis (LET) and demonstrated that the addition of the LET reduced the risk of instability (RRR=0.38; 95% Confidence Interval (CI), 0.21-0.52; P=0.0001) and graft re-rupture (RRR, 0.67; 95% CI, 0.36-0.83; P=0.001). As a result, practice has changed; there has been a large increase in the proportion of orthopaedic surgeons recommending the addition of an LET at the time of ACLR and an increase in the number of patients requesting an LET from their surgeon. There is some weak evidence suggesting that in the longer term, the LET may increase the risk of developing osteoarthritis (OA) in that knee. Knee OA affects over 4.4 million Canadians and the number of younger adults being diagnosed with knee OA is growing and is a primary reason for seeking healthcare in Canada. The impact of OA in Canada is enormous and projected to cost Canada $17.5 billion annually in lost productivity alone by 2031. This study will use imaging and patient-reported Knee Outcomes Osteoarthritis Score (KOOS) to evaluate the incidence of OA at 10-years post ACL reconstruction with and without LET. We will also collect information about overall knee health, patient-reported outcomes, costs associated with knee injury, rehabilitation and disability, clinical failure, functional ability, and sport participation. It is crucial that we understand the risks of developing knee OA associated with the addition of an LET to an ACLR so that surgeons and patients can make informed decisions, not just for their immediate post injury treatment of the failed ligament, but for the potential long-term consequences of that decision.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2024
Typical duration for not_applicable
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2024
CompletedFirst Submitted
Initial submission to the registry
March 13, 2025
CompletedFirst Posted
Study publicly available on registry
March 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
March 20, 2025
February 1, 2025
2.3 years
March 13, 2025
March 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Lateral compartment knee OA
As was conducted at baseline and two years postoperative in the Stability 1 study, patients will undergo a standing semi-flexed posterior to anterior (PA) radiograph of both knees.
10 Years
Region-specific quality of life using the Knee Osteoarthritis and outcomes Score (KOOS)
The KOOS is a 42-item knee-specific questionnaire with five separately reported domains, including pain (9 items), other symptoms (7 items), function in daily living (17 items), function in sports/recreation (5 items) and knee-related quality of life (4 items). Domain scores represent the average of all items in the domain standardized to a score from 0 to 100 (worst to best). This instrument has face validity and has demonstrated construct validity, excellent test-retest reliability for each domain (range, 0.75 to 0.93) and has been shown to be responsive to change in patients undergoing ACLR.
10 Years
Secondary Outcomes (9)
Disease-specific quality of life using the ACL Quality of Life Questionnaire (ACL-QOL)
10 Years
The Marx Activity Rating Scale (MARS)
10 Years
Subjective symptoms, function and activity (IKDC)
10 Years
MRI
10 Years
Patient Reported Quality of Life (ACL QOL)
10 Years
- +4 more secondary outcomes
Study Arms (2)
ACL Reconstruction
ACTIVE COMPARATORStandard ACL reconstruction only.
ACL + LET
EXPERIMENTALAnatomic ACL reconstruction following the same procedure as the active comparator group with an added lateral extra-articular tenodesis (LET).
Interventions
Lateral extra-articular tenodesis: A 1cm wide x 8cm long strip of iliotibial band is fashioned, leaving the Gerdys tubercle attachment intact. The graft is tunneled under the fibular collateral ligament (FCL) and attached to the femur with a Richards' staple (Smith \& Nephew), just distal to the intermuscular septum, proximal to the femoral insertion of the FCL. Fixation is performed with the knee at 70 degrees flexion, neutral rotation. Minimal tension is applied to the graft. The free end is then looped back onto itself and sutured using the No. 1 vicryl.
Anatomic ACL reconstruction using a four-strand autologous hamstring graft. If the diameter of the graft is found to be less than 7.5mm, semitendinosus will be tripled (5 strand graft) providing a greater graft diameter. Femoral tunnels will be drilled using an anteromedial portal technique, with femoral fixation provided by an Endobutton or equivalent. Tibial fixation will be provided by interference screw.
Eligibility Criteria
You may qualify if:
- ACL deficient knee
- skeletally mature to 25 years of age
- or more of:
- competitive pivoting sport
- grade 2 pivot shift or greater
- generalized ligament laxity - Beighton score of 4 or greater
You may not qualify if:
- previous ACL reconstruction on either knee
- multi-ligament injury (two or more ligaments requiring surgical attention)
- symptomatic articular cartilage defect requiring treatment other than debridement
- greater than 3 degrees of asymmetric varus
- unable to complete outcome questionnaires
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
Banff Sport Medicine Clinic
Banff, Alberta, T1L 1B3, Canada
University of Calgary
Calgary, Alberta, T2N 1N4, Canada
Fraser Health Authority
New Westminster, British Columbia, V3L 5P5, Canada
Pan Am Clinic
Winnipeg, Manitoba, R3M 3E4, Canada
McMaster University
Hamilton, Ontario, L8N 3Z5, Canada
Queens University
Kingston, Ontario, K7L 2V7, Canada
Fowler Kennedy Sport Medicine Clinic
London, Ontario, N6A 3K7, Canada
University Hospitals Coventry and Warwickshire NHS Trust
Coventry, CV2 2DX, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 13, 2025
First Posted
March 20, 2025
Study Start
November 1, 2024
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
March 1, 2027
Last Updated
March 20, 2025
Record last verified: 2025-02